LMNA and Arrhythmogenic right ventricular dysplasia: Techniques such as extended culture periods, the introduction of oxidative stressors, the shift to adult metabolic profiles, and the expression of aging-associated proteins like progerin have been applied to model adult-onset diseases, including Parkinson’s disease and arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVC/D) (63–65).